Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-61.27	16.12	41.61
Graham Fair Price	41.42	1.00	0.71
PEG	-65.45	0.21	-0.61
Price/Book	-3.69	1.46	1.52
Price/Cash Flow	-26.10	11.02	14.92
Prices/Earnings	-51.85	21.08	43.78
Price/Sales	-44.06	1.45	2.60
Price/FCF	-26.10	11.02	14.92
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-76.05	0.10	0.43
Operating Margin	16.68	0.05	0.05
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	0.02	100.00
ROIC	< 0.005	0.02	104.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	0.19	-99.05
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.60	1.01	69.18
EPS QOQ	-0.72	1.01	39.39
FCF QOQ	2.16	0.30	-85.94
Revenue QOQ	-0.45	0.72	60.66
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	100.69	38.33	-61.93
Days Sales Outstanding (DSO)	77.91	54.93	-29.49
Inventory Turnover	0.89	2.35	162.70
Debt/Capitalization	0.58	0.57	-1.41
Quick Ratio	0.77	0.86	12.88
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.61	1.61	< 0.005
Cash	0.59	0.59	< 0.005
Capex	-0.14	-0.40	-180.72
Free Cash Flow	0.16	0.21	30.32
Revenue	0.94	1.62	72.15
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.22	1.22	0.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	16.84	6.66	-60.46
Naive Interpretation	Member

06 - Financial Health · Weak

Rating